Research on the treatment of rifampin-susceptible tuberculosis-Time for a new approach

In the Perspective, William Burman and colleagues advocate improving the safety and acceptability of treatment, rather than treatment-shortening, of rifampin-susceptible tuberculosis.

Saved in:
Bibliographic Details
Published in:PLoS medicine 2024-07, Vol.21 (7), p.e1004438
Main Authors: Burman, William, Rucsineanu, Oxana, Horsburgh, C Robert, Johnston, James, Dorman, Susan E, Menzies, Dick
Format: Article
Language:English
Subjects:
Antitubercular agents
Antitubercular Agents - adverse effects
Antitubercular Agents - therapeutic use
Biology and Life Sciences
Drug resistance in microorganisms
Drug therapy
Humans
Medicine and Health Sciences
Mycobacterium tuberculosis - drug effects
Pharmaceutical research
Research and Analysis Methods
Rifampin - therapeutic use
Tuberculosis
Tuberculosis - drug therapy
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:In the Perspective, William Burman and colleagues advocate improving the safety and acceptability of treatment, rather than treatment-shortening, of rifampin-susceptible tuberculosis.
ISSN:1549-1676
1549-1277
1549-1676
DOI:10.1371/journal.pmed.1004438